Wet Heparinized Suction for Abdominal Cancer

NCT05041335 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-04-22

No results posted yet for this study

Summary

The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or "blood thinner" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptability of the specimens before sending for analysis.

You will be randomly assigned (like a flip of a coin) to have either the blood thinner or the salt water solution placed within the needle being used to sample your abdominal tumor and to have either a sieve used or not.

You will be one of 42 participants enrolled in this data collection study which includes 1 sites in the United States.

Conditions

  • Cancer of Pancreas
  • Cancer of Stomach
  • Cancer of Esophagus
  • Cancer of Liver
  • Cancer

Interventions

OTHER

wet heparinzed suction

Needle flushed with 5000 Units in 10mL of heparin

OTHER

Microsieve

A microsieve used for tissue preparation

OTHER

No heparin flush

The needle not prepped

OTHER

No microsieve

The tissue is placed into formalin

Sponsors & Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Shaffer Mok, MD · Moffitt Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-15
Primary Completion
2027-01-12
Completion
2027-01-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05041335 on ClinicalTrials.gov